DTIL

Precision BioSciences, Inc.

DTIL · CIK 1357874 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$0.1B
20192024
Net Income$0.0B
20192024
Operating CF−$0.1B
20192024
Free Cash Flow
20192024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue$0.1B$0.0B$0.0B$0.1B$0.0B$1.1B
Cost of Revenue——————
Gross Profit——————
R&D Expense$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
SG&A Expense——————
Operating Income$-0.0B$-0.0B$-0.1B$-0.0B$-0.1B$-0.1B
Net Income$0.0B$-0.1B$-0.1B$-0.0B$-0.1B$-0.1B
EPS (Basic)$1.05$-15.96$-1.27———
EPS (Diluted)$1.04$-15.96$-1.27———

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$0.1B$0.2B$0.2B$0.2B$0.2B$0.2B
Current Assets$0.1B$0.1B$0.2B$0.2B$0.1B$0.2B
Cash & Equivalents$0.1B$0.1B$0.2B$0.1B$0.1B$0.2B
Total Liabilities$0.1B$0.1B$0.2B$0.1B$0.1B$0.1B
Current Liabilities$0.0B$0.0B$0.1B$0.0B$0.0B$0.0B
Stockholders' Equity$0.1B$0.0B$0.1B$0.1B$0.0B$0.1B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$-0.1B$-0.1B$-0.0B$-0.0B$-0.1B$-0.1B
Investing Cash Flow$-0.0B$0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Capital Expenditures——————
Financing Cash Flow$0.1B$0.0B$0.1B$0.1B$0.0B$0.2B
← Companies